Global Infectious Disease Biomarker Testing Market Research Report 2026(Status and Outlook)
The global Infectious Disease Biomarker Testing market size was estimated at USD 1925.4 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 8.65% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Infectious Disease Biomarker Testing market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Infectious Disease Biomarker Testing market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Infectious Disease Biomarker Testing market.
Global Infectious Disease Biomarker Testing Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Abacus Diagnostica
ALPCO
Abbott Laboratories
Agilent Technologies
Becton
Dickinson and Company
bioM?rieux SA
Bio-Rad Laboratories
Danaher
F. Hoffmann-La Roche
Hologic
PerkinElmer
Qiagen
Quest Diagnostics Incorporated
Siemens Healthineers
Thermo Fisher Scientific
Market Segmentation (by Type)
PCR
NGS
ELISA or EIA
IHC
ISH
Others
Market Segmentation (by Application)
Hospitals and Clinics
Diagnostic Centers
Academic Research Institutes
Others
Geographic Segmentation
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Infectious Disease Biomarker Testing Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Infectious Disease Biomarker Testing, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
This report offers a comprehensive and in-depth analysis of the global Infectious Disease Biomarker Testing market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Infectious Disease Biomarker Testing market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Infectious Disease Biomarker Testing market.
Global Infectious Disease Biomarker Testing Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Abacus Diagnostica
ALPCO
Abbott Laboratories
Agilent Technologies
Becton
Dickinson and Company
bioM?rieux SA
Bio-Rad Laboratories
Danaher
F. Hoffmann-La Roche
Hologic
PerkinElmer
Qiagen
Quest Diagnostics Incorporated
Siemens Healthineers
Thermo Fisher Scientific
Market Segmentation (by Type)
PCR
NGS
ELISA or EIA
IHC
ISH
Others
Market Segmentation (by Application)
Hospitals and Clinics
Diagnostic Centers
Academic Research Institutes
Others
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Infectious Disease Biomarker Testing Market
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Infectious Disease Biomarker Testing Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Infectious Disease Biomarker Testing, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Infectious Disease Biomarker Testing
1.2 Key Market Segments
1.2.1 Infectious Disease Biomarker Testing Segment by Type
1.2.2 Infectious Disease Biomarker Testing Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 INFECTIOUS DISEASE BIOMARKER TESTING MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Infectious Disease Biomarker Testing Market Size (M USD) Estimates and Forecasts (2020-2035)
2.1.2 Global Infectious Disease Biomarker Testing Sales Estimates and Forecasts (2020-2035)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 INFECTIOUS DISEASE BIOMARKER TESTING MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Infectious Disease Biomarker Testing Product Life Cycle
3.3 Global Infectious Disease Biomarker Testing Sales by Manufacturers (2020-2025)
3.4 Global Infectious Disease Biomarker Testing Revenue Market Share by Manufacturers (2020-2025)
3.5 Infectious Disease Biomarker Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Infectious Disease Biomarker Testing Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Infectious Disease Biomarker Testing Market Competitive Situation and Trends
3.8.1 Infectious Disease Biomarker Testing Market Concentration Rate
3.8.2 Global 5 and 10 Largest Infectious Disease Biomarker Testing Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 INFECTIOUS DISEASE BIOMARKER TESTING INDUSTRY CHAIN ANALYSIS
4.1 Infectious Disease Biomarker Testing Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF INFECTIOUS DISEASE BIOMARKER TESTING MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Infectious Disease Biomarker Testing Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to Infectious Disease Biomarker Testing Market
5.7 ESG Ratings of Leading Companies
6 INFECTIOUS DISEASE BIOMARKER TESTING MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Infectious Disease Biomarker Testing Sales Market Share by Type (2020-2025)
6.3 Global Infectious Disease Biomarker Testing Market Size by Type (2020-2025)
6.4 Global Infectious Disease Biomarker Testing Price by Type (2020-2025)
7 INFECTIOUS DISEASE BIOMARKER TESTING MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Infectious Disease Biomarker Testing Market Sales by Application (2020-2025)
7.3 Global Infectious Disease Biomarker Testing Market Size (M USD) by Application (2020-2025)
7.4 Global Infectious Disease Biomarker Testing Sales Growth Rate by Application (2020-2025)
8 INFECTIOUS DISEASE BIOMARKER TESTING MARKET SALES BY REGION
8.1 Global Infectious Disease Biomarker Testing Sales by Region
8.1.1 Global Infectious Disease Biomarker Testing Sales by Region
8.1.2 Global Infectious Disease Biomarker Testing Sales Market Share by Region
8.2 Global Infectious Disease Biomarker Testing Market Size by Region
8.2.1 Global Infectious Disease Biomarker Testing Market Size by Region
8.2.2 Global Infectious Disease Biomarker Testing Market Size by Region
8.3 North America
8.3.1 North America Infectious Disease Biomarker Testing Sales by Country
8.3.2 North America Infectious Disease Biomarker Testing Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Infectious Disease Biomarker Testing Sales by Country
8.4.2 Europe Infectious Disease Biomarker Testing Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Infectious Disease Biomarker Testing Sales by Region
8.5.2 Asia Pacific Infectious Disease Biomarker Testing Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Infectious Disease Biomarker Testing Sales by Country
8.6.2 South America Infectious Disease Biomarker Testing Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Infectious Disease Biomarker Testing Sales by Region
8.7.2 Middle East and Africa Infectious Disease Biomarker Testing Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 INFECTIOUS DISEASE BIOMARKER TESTING MARKET PRODUCTION BY REGION
9.1 Global Production of Infectious Disease Biomarker Testing by Region(2020-2025)
9.2 Global Infectious Disease Biomarker Testing Revenue Market Share by Region (2020-2025)
9.3 Global Infectious Disease Biomarker Testing Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Infectious Disease Biomarker Testing Production
9.4.1 North America Infectious Disease Biomarker Testing Production Growth Rate (2020-2025)
9.4.2 North America Infectious Disease Biomarker Testing Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Infectious Disease Biomarker Testing Production
9.5.1 Europe Infectious Disease Biomarker Testing Production Growth Rate (2020-2025)
9.5.2 Europe Infectious Disease Biomarker Testing Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Infectious Disease Biomarker Testing Production (2020-2025)
9.6.1 Japan Infectious Disease Biomarker Testing Production Growth Rate (2020-2025)
9.6.2 Japan Infectious Disease Biomarker Testing Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Infectious Disease Biomarker Testing Production (2020-2025)
9.7.1 China Infectious Disease Biomarker Testing Production Growth Rate (2020-2025)
9.7.2 China Infectious Disease Biomarker Testing Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Abacus Diagnostica
10.1.1 Abacus Diagnostica Basic Information
10.1.2 Abacus Diagnostica Infectious Disease Biomarker Testing Product Overview
10.1.3 Abacus Diagnostica Infectious Disease Biomarker Testing Product Market Performance
10.1.4 Abacus Diagnostica Business Overview
10.1.5 Abacus Diagnostica SWOT Analysis
10.1.6 Abacus Diagnostica Recent Developments
10.2 ALPCO
10.2.1 ALPCO Basic Information
10.2.2 ALPCO Infectious Disease Biomarker Testing Product Overview
10.2.3 ALPCO Infectious Disease Biomarker Testing Product Market Performance
10.2.4 ALPCO Business Overview
10.2.5 ALPCO SWOT Analysis
10.2.6 ALPCO Recent Developments
10.3 Abbott Laboratories
10.3.1 Abbott Laboratories Basic Information
10.3.2 Abbott Laboratories Infectious Disease Biomarker Testing Product Overview
10.3.3 Abbott Laboratories Infectious Disease Biomarker Testing Product Market Performance
10.3.4 Abbott Laboratories Business Overview
10.3.5 Abbott Laboratories SWOT Analysis
10.3.6 Abbott Laboratories Recent Developments
10.4 Agilent Technologies
10.4.1 Agilent Technologies Basic Information
10.4.2 Agilent Technologies Infectious Disease Biomarker Testing Product Overview
10.4.3 Agilent Technologies Infectious Disease Biomarker Testing Product Market Performance
10.4.4 Agilent Technologies Business Overview
10.4.5 Agilent Technologies Recent Developments
10.5 Becton
10.5.1 Becton Basic Information
10.5.2 Becton Infectious Disease Biomarker Testing Product Overview
10.5.3 Becton Infectious Disease Biomarker Testing Product Market Performance
10.5.4 Becton Business Overview
10.5.5 Becton Recent Developments
10.6 Dickinson and Company
10.6.1 Dickinson and Company Basic Information
10.6.2 Dickinson and Company Infectious Disease Biomarker Testing Product Overview
10.6.3 Dickinson and Company Infectious Disease Biomarker Testing Product Market Performance
10.6.4 Dickinson and Company Business Overview
10.6.5 Dickinson and Company Recent Developments
10.7 bioM?rieux SA
10.7.1 bioM?rieux SA Basic Information
10.7.2 bioM?rieux SA Infectious Disease Biomarker Testing Product Overview
10.7.3 bioM?rieux SA Infectious Disease Biomarker Testing Product Market Performance
10.7.4 bioM?rieux SA Business Overview
10.7.5 bioM?rieux SA Recent Developments
10.8 Bio-Rad Laboratories
10.8.1 Bio-Rad Laboratories Basic Information
10.8.2 Bio-Rad Laboratories Infectious Disease Biomarker Testing Product Overview
10.8.3 Bio-Rad Laboratories Infectious Disease Biomarker Testing Product Market Performance
10.8.4 Bio-Rad Laboratories Business Overview
10.8.5 Bio-Rad Laboratories Recent Developments
10.9 Danaher
10.9.1 Danaher Basic Information
10.9.2 Danaher Infectious Disease Biomarker Testing Product Overview
10.9.3 Danaher Infectious Disease Biomarker Testing Product Market Performance
10.9.4 Danaher Business Overview
10.9.5 Danaher Recent Developments
10.10 F. Hoffmann-La Roche
10.10.1 F. Hoffmann-La Roche Basic Information
10.10.2 F. Hoffmann-La Roche Infectious Disease Biomarker Testing Product Overview
10.10.3 F. Hoffmann-La Roche Infectious Disease Biomarker Testing Product Market Performance
10.10.4 F. Hoffmann-La Roche Business Overview
10.10.5 F. Hoffmann-La Roche Recent Developments
10.11 Hologic
10.11.1 Hologic Basic Information
10.11.2 Hologic Infectious Disease Biomarker Testing Product Overview
10.11.3 Hologic Infectious Disease Biomarker Testing Product Market Performance
10.11.4 Hologic Business Overview
10.11.5 Hologic Recent Developments
10.12 PerkinElmer
10.12.1 PerkinElmer Basic Information
10.12.2 PerkinElmer Infectious Disease Biomarker Testing Product Overview
10.12.3 PerkinElmer Infectious Disease Biomarker Testing Product Market Performance
10.12.4 PerkinElmer Business Overview
10.12.5 PerkinElmer Recent Developments
10.13 Qiagen
10.13.1 Qiagen Basic Information
10.13.2 Qiagen Infectious Disease Biomarker Testing Product Overview
10.13.3 Qiagen Infectious Disease Biomarker Testing Product Market Performance
10.13.4 Qiagen Business Overview
10.13.5 Qiagen Recent Developments
10.14 Quest Diagnostics Incorporated
10.14.1 Quest Diagnostics Incorporated Basic Information
10.14.2 Quest Diagnostics Incorporated Infectious Disease Biomarker Testing Product Overview
10.14.3 Quest Diagnostics Incorporated Infectious Disease Biomarker Testing Product Market Performance
10.14.4 Quest Diagnostics Incorporated Business Overview
10.14.5 Quest Diagnostics Incorporated Recent Developments
10.15 Siemens Healthineers
10.15.1 Siemens Healthineers Basic Information
10.15.2 Siemens Healthineers Infectious Disease Biomarker Testing Product Overview
10.15.3 Siemens Healthineers Infectious Disease Biomarker Testing Product Market Performance
10.15.4 Siemens Healthineers Business Overview
10.15.5 Siemens Healthineers Recent Developments
10.16 Thermo Fisher Scientific
10.16.1 Thermo Fisher Scientific Basic Information
10.16.2 Thermo Fisher Scientific Infectious Disease Biomarker Testing Product Overview
10.16.3 Thermo Fisher Scientific Infectious Disease Biomarker Testing Product Market Performance
10.16.4 Thermo Fisher Scientific Business Overview
10.16.5 Thermo Fisher Scientific Recent Developments
11 INFECTIOUS DISEASE BIOMARKER TESTING MARKET FORECAST BY REGION
11.1 Global Infectious Disease Biomarker Testing Market Size Forecast
11.2 Global Infectious Disease Biomarker Testing Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Infectious Disease Biomarker Testing Market Size Forecast by Country
11.2.3 Asia Pacific Infectious Disease Biomarker Testing Market Size Forecast by Region
11.2.4 South America Infectious Disease Biomarker Testing Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Infectious Disease Biomarker Testing by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)
12.1 Global Infectious Disease Biomarker Testing Market Forecast by Type (2026-2035)
12.1.1 Global Forecasted Sales of Infectious Disease Biomarker Testing by Type (2026-2035)
12.1.2 Global Infectious Disease Biomarker Testing Market Size Forecast by Type (2026-2035)
12.1.3 Global Forecasted Price of Infectious Disease Biomarker Testing by Type (2026-2035)
12.2 Global Infectious Disease Biomarker Testing Market Forecast by Application (2026-2035)
12.2.1 Global Infectious Disease Biomarker Testing Sales (K Units) Forecast by Application
12.2.2 Global Infectious Disease Biomarker Testing Market Size (M USD) Forecast by Application (2026-2035)
13 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Infectious Disease Biomarker Testing
1.2 Key Market Segments
1.2.1 Infectious Disease Biomarker Testing Segment by Type
1.2.2 Infectious Disease Biomarker Testing Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 INFECTIOUS DISEASE BIOMARKER TESTING MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Infectious Disease Biomarker Testing Market Size (M USD) Estimates and Forecasts (2020-2035)
2.1.2 Global Infectious Disease Biomarker Testing Sales Estimates and Forecasts (2020-2035)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 INFECTIOUS DISEASE BIOMARKER TESTING MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Infectious Disease Biomarker Testing Product Life Cycle
3.3 Global Infectious Disease Biomarker Testing Sales by Manufacturers (2020-2025)
3.4 Global Infectious Disease Biomarker Testing Revenue Market Share by Manufacturers (2020-2025)
3.5 Infectious Disease Biomarker Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Infectious Disease Biomarker Testing Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Infectious Disease Biomarker Testing Market Competitive Situation and Trends
3.8.1 Infectious Disease Biomarker Testing Market Concentration Rate
3.8.2 Global 5 and 10 Largest Infectious Disease Biomarker Testing Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 INFECTIOUS DISEASE BIOMARKER TESTING INDUSTRY CHAIN ANALYSIS
4.1 Infectious Disease Biomarker Testing Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF INFECTIOUS DISEASE BIOMARKER TESTING MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Infectious Disease Biomarker Testing Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to Infectious Disease Biomarker Testing Market
5.7 ESG Ratings of Leading Companies
6 INFECTIOUS DISEASE BIOMARKER TESTING MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Infectious Disease Biomarker Testing Sales Market Share by Type (2020-2025)
6.3 Global Infectious Disease Biomarker Testing Market Size by Type (2020-2025)
6.4 Global Infectious Disease Biomarker Testing Price by Type (2020-2025)
7 INFECTIOUS DISEASE BIOMARKER TESTING MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Infectious Disease Biomarker Testing Market Sales by Application (2020-2025)
7.3 Global Infectious Disease Biomarker Testing Market Size (M USD) by Application (2020-2025)
7.4 Global Infectious Disease Biomarker Testing Sales Growth Rate by Application (2020-2025)
8 INFECTIOUS DISEASE BIOMARKER TESTING MARKET SALES BY REGION
8.1 Global Infectious Disease Biomarker Testing Sales by Region
8.1.1 Global Infectious Disease Biomarker Testing Sales by Region
8.1.2 Global Infectious Disease Biomarker Testing Sales Market Share by Region
8.2 Global Infectious Disease Biomarker Testing Market Size by Region
8.2.1 Global Infectious Disease Biomarker Testing Market Size by Region
8.2.2 Global Infectious Disease Biomarker Testing Market Size by Region
8.3 North America
8.3.1 North America Infectious Disease Biomarker Testing Sales by Country
8.3.2 North America Infectious Disease Biomarker Testing Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Infectious Disease Biomarker Testing Sales by Country
8.4.2 Europe Infectious Disease Biomarker Testing Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Infectious Disease Biomarker Testing Sales by Region
8.5.2 Asia Pacific Infectious Disease Biomarker Testing Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Infectious Disease Biomarker Testing Sales by Country
8.6.2 South America Infectious Disease Biomarker Testing Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Infectious Disease Biomarker Testing Sales by Region
8.7.2 Middle East and Africa Infectious Disease Biomarker Testing Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 INFECTIOUS DISEASE BIOMARKER TESTING MARKET PRODUCTION BY REGION
9.1 Global Production of Infectious Disease Biomarker Testing by Region(2020-2025)
9.2 Global Infectious Disease Biomarker Testing Revenue Market Share by Region (2020-2025)
9.3 Global Infectious Disease Biomarker Testing Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Infectious Disease Biomarker Testing Production
9.4.1 North America Infectious Disease Biomarker Testing Production Growth Rate (2020-2025)
9.4.2 North America Infectious Disease Biomarker Testing Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Infectious Disease Biomarker Testing Production
9.5.1 Europe Infectious Disease Biomarker Testing Production Growth Rate (2020-2025)
9.5.2 Europe Infectious Disease Biomarker Testing Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Infectious Disease Biomarker Testing Production (2020-2025)
9.6.1 Japan Infectious Disease Biomarker Testing Production Growth Rate (2020-2025)
9.6.2 Japan Infectious Disease Biomarker Testing Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Infectious Disease Biomarker Testing Production (2020-2025)
9.7.1 China Infectious Disease Biomarker Testing Production Growth Rate (2020-2025)
9.7.2 China Infectious Disease Biomarker Testing Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Abacus Diagnostica
10.1.1 Abacus Diagnostica Basic Information
10.1.2 Abacus Diagnostica Infectious Disease Biomarker Testing Product Overview
10.1.3 Abacus Diagnostica Infectious Disease Biomarker Testing Product Market Performance
10.1.4 Abacus Diagnostica Business Overview
10.1.5 Abacus Diagnostica SWOT Analysis
10.1.6 Abacus Diagnostica Recent Developments
10.2 ALPCO
10.2.1 ALPCO Basic Information
10.2.2 ALPCO Infectious Disease Biomarker Testing Product Overview
10.2.3 ALPCO Infectious Disease Biomarker Testing Product Market Performance
10.2.4 ALPCO Business Overview
10.2.5 ALPCO SWOT Analysis
10.2.6 ALPCO Recent Developments
10.3 Abbott Laboratories
10.3.1 Abbott Laboratories Basic Information
10.3.2 Abbott Laboratories Infectious Disease Biomarker Testing Product Overview
10.3.3 Abbott Laboratories Infectious Disease Biomarker Testing Product Market Performance
10.3.4 Abbott Laboratories Business Overview
10.3.5 Abbott Laboratories SWOT Analysis
10.3.6 Abbott Laboratories Recent Developments
10.4 Agilent Technologies
10.4.1 Agilent Technologies Basic Information
10.4.2 Agilent Technologies Infectious Disease Biomarker Testing Product Overview
10.4.3 Agilent Technologies Infectious Disease Biomarker Testing Product Market Performance
10.4.4 Agilent Technologies Business Overview
10.4.5 Agilent Technologies Recent Developments
10.5 Becton
10.5.1 Becton Basic Information
10.5.2 Becton Infectious Disease Biomarker Testing Product Overview
10.5.3 Becton Infectious Disease Biomarker Testing Product Market Performance
10.5.4 Becton Business Overview
10.5.5 Becton Recent Developments
10.6 Dickinson and Company
10.6.1 Dickinson and Company Basic Information
10.6.2 Dickinson and Company Infectious Disease Biomarker Testing Product Overview
10.6.3 Dickinson and Company Infectious Disease Biomarker Testing Product Market Performance
10.6.4 Dickinson and Company Business Overview
10.6.5 Dickinson and Company Recent Developments
10.7 bioM?rieux SA
10.7.1 bioM?rieux SA Basic Information
10.7.2 bioM?rieux SA Infectious Disease Biomarker Testing Product Overview
10.7.3 bioM?rieux SA Infectious Disease Biomarker Testing Product Market Performance
10.7.4 bioM?rieux SA Business Overview
10.7.5 bioM?rieux SA Recent Developments
10.8 Bio-Rad Laboratories
10.8.1 Bio-Rad Laboratories Basic Information
10.8.2 Bio-Rad Laboratories Infectious Disease Biomarker Testing Product Overview
10.8.3 Bio-Rad Laboratories Infectious Disease Biomarker Testing Product Market Performance
10.8.4 Bio-Rad Laboratories Business Overview
10.8.5 Bio-Rad Laboratories Recent Developments
10.9 Danaher
10.9.1 Danaher Basic Information
10.9.2 Danaher Infectious Disease Biomarker Testing Product Overview
10.9.3 Danaher Infectious Disease Biomarker Testing Product Market Performance
10.9.4 Danaher Business Overview
10.9.5 Danaher Recent Developments
10.10 F. Hoffmann-La Roche
10.10.1 F. Hoffmann-La Roche Basic Information
10.10.2 F. Hoffmann-La Roche Infectious Disease Biomarker Testing Product Overview
10.10.3 F. Hoffmann-La Roche Infectious Disease Biomarker Testing Product Market Performance
10.10.4 F. Hoffmann-La Roche Business Overview
10.10.5 F. Hoffmann-La Roche Recent Developments
10.11 Hologic
10.11.1 Hologic Basic Information
10.11.2 Hologic Infectious Disease Biomarker Testing Product Overview
10.11.3 Hologic Infectious Disease Biomarker Testing Product Market Performance
10.11.4 Hologic Business Overview
10.11.5 Hologic Recent Developments
10.12 PerkinElmer
10.12.1 PerkinElmer Basic Information
10.12.2 PerkinElmer Infectious Disease Biomarker Testing Product Overview
10.12.3 PerkinElmer Infectious Disease Biomarker Testing Product Market Performance
10.12.4 PerkinElmer Business Overview
10.12.5 PerkinElmer Recent Developments
10.13 Qiagen
10.13.1 Qiagen Basic Information
10.13.2 Qiagen Infectious Disease Biomarker Testing Product Overview
10.13.3 Qiagen Infectious Disease Biomarker Testing Product Market Performance
10.13.4 Qiagen Business Overview
10.13.5 Qiagen Recent Developments
10.14 Quest Diagnostics Incorporated
10.14.1 Quest Diagnostics Incorporated Basic Information
10.14.2 Quest Diagnostics Incorporated Infectious Disease Biomarker Testing Product Overview
10.14.3 Quest Diagnostics Incorporated Infectious Disease Biomarker Testing Product Market Performance
10.14.4 Quest Diagnostics Incorporated Business Overview
10.14.5 Quest Diagnostics Incorporated Recent Developments
10.15 Siemens Healthineers
10.15.1 Siemens Healthineers Basic Information
10.15.2 Siemens Healthineers Infectious Disease Biomarker Testing Product Overview
10.15.3 Siemens Healthineers Infectious Disease Biomarker Testing Product Market Performance
10.15.4 Siemens Healthineers Business Overview
10.15.5 Siemens Healthineers Recent Developments
10.16 Thermo Fisher Scientific
10.16.1 Thermo Fisher Scientific Basic Information
10.16.2 Thermo Fisher Scientific Infectious Disease Biomarker Testing Product Overview
10.16.3 Thermo Fisher Scientific Infectious Disease Biomarker Testing Product Market Performance
10.16.4 Thermo Fisher Scientific Business Overview
10.16.5 Thermo Fisher Scientific Recent Developments
11 INFECTIOUS DISEASE BIOMARKER TESTING MARKET FORECAST BY REGION
11.1 Global Infectious Disease Biomarker Testing Market Size Forecast
11.2 Global Infectious Disease Biomarker Testing Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Infectious Disease Biomarker Testing Market Size Forecast by Country
11.2.3 Asia Pacific Infectious Disease Biomarker Testing Market Size Forecast by Region
11.2.4 South America Infectious Disease Biomarker Testing Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Infectious Disease Biomarker Testing by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)
12.1 Global Infectious Disease Biomarker Testing Market Forecast by Type (2026-2035)
12.1.1 Global Forecasted Sales of Infectious Disease Biomarker Testing by Type (2026-2035)
12.1.2 Global Infectious Disease Biomarker Testing Market Size Forecast by Type (2026-2035)
12.1.3 Global Forecasted Price of Infectious Disease Biomarker Testing by Type (2026-2035)
12.2 Global Infectious Disease Biomarker Testing Market Forecast by Application (2026-2035)
12.2.1 Global Infectious Disease Biomarker Testing Sales (K Units) Forecast by Application
12.2.2 Global Infectious Disease Biomarker Testing Market Size (M USD) Forecast by Application (2026-2035)
13 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Infectious Disease Biomarker Testing Market Size by Type (M USD)
Table 4. Global Infectious Disease Biomarker Testing Market Size by Application
Table 5. Infectious Disease Biomarker Testing Market Size Comparison by Region (M USD)
Table 6. Global Infectious Disease Biomarker Testing Sales (K Units) by Manufacturers (2020-2025)
Table 7. Global Infectious Disease Biomarker Testing Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Infectious Disease Biomarker Testing Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Infectious Disease Biomarker Testing Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Infectious Disease Biomarker Testing as of 2025)
Table 11. Global Market Infectious Disease Biomarker Testing Average Price (USD/Unit) of Key Manufacturers (2020-2025)
Table 12. Manufacturers? Manufacturing Sites, Areas Served
Table 13. Manufacturers? Product Type
Table 14. Global Infectious Disease Biomarker Testing Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Infectious Disease Biomarker Testing Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2025-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2025-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2025-2026
Table 25. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 26. Global Infectious Disease Biomarker Testing Sales by Type (K Units)
Table 27. Global Infectious Disease Biomarker Testing Market Size by Type (M USD)
Table 28. Global Infectious Disease Biomarker Testing Sales (K Units) by Type (2020-2025)
Table 29. Global Infectious Disease Biomarker Testing Sales Market Share by Type (2020-2025)
Table 30. Global Infectious Disease Biomarker Testing Market Size (M USD) by Type (2020-2025)
Table 31. Global Infectious Disease Biomarker Testing Market Share by Type (2020-2025)
Table 32. Global Infectious Disease Biomarker Testing Price (USD/Unit) by Type (2020-2025)
Table 33. Global Infectious Disease Biomarker Testing Sales (K Units) by Application
Table 34. Global Infectious Disease Biomarker Testing Market Size by Application
Table 35. Global Infectious Disease Biomarker Testing Sales by Application (2020-2025) & (K Units)
Table 36. Global Infectious Disease Biomarker Testing Sales Market Share by Application (2020-2025)
Table 37. Global Infectious Disease Biomarker Testing Market Size by Application (2020-2025) & (M USD)
Table 38. Global Infectious Disease Biomarker Testing Market Share by Application (2020-2025)
Table 39. Global Infectious Disease Biomarker Testing Sales Growth Rate by Application (2020-2025)
Table 40. Global Infectious Disease Biomarker Testing Sales by Region (2020-2025) & (K Units)
Table 41. Global Infectious Disease Biomarker Testing Sales Market Share by Region (2020-2025)
Table 42. Global Infectious Disease Biomarker Testing Market Size by Region (2020-2025) & (M USD)
Table 43. Global Infectious Disease Biomarker Testing Market Size by Region (2020-2025)
Table 44. North America Infectious Disease Biomarker Testing Sales by Country (2020-2025) & (K Units)
Table 45. North America Infectious Disease Biomarker Testing Market Size by Country (2020-2025) & (M USD)
Table 46. Europe Infectious Disease Biomarker Testing Sales by Country (2020-2025) & (K Units)
Table 47. Europe Infectious Disease Biomarker Testing Market Size by Country (2020-2025) & (M USD)
Table 48. Asia Pacific Infectious Disease Biomarker Testing Sales by Region (2020-2025) & (K Units)
Table 49. Asia Pacific Infectious Disease Biomarker Testing Market Size by Region (2020-2025) & (M USD)
Table 50. South America Infectious Disease Biomarker Testing Sales by Country (2020-2025) & (K Units)
Table 51. South America Infectious Disease Biomarker Testing Market Size by Country (2020-2025) & (M USD)
Table 52. Middle East and Africa Infectious Disease Biomarker Testing Sales by Region (2020-2025) & (K Units)
Table 53. Middle East and Africa Infectious Disease Biomarker Testing Market Size by Region (2020-2025) & (M USD)
Table 54. Global Infectious Disease Biomarker Testing Production (K Units) by Region(2020-2025)
Table 55. Global Infectious Disease Biomarker Testing Revenue (US$ Million) by Region (2020-2025)
Table 56. Global Infectious Disease Biomarker Testing Revenue Market Share by Region (2020-2025)
Table 57. Global Infectious Disease Biomarker Testing Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 58. North America Infectious Disease Biomarker Testing Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 59. Europe Infectious Disease Biomarker Testing Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 60. Japan Infectious Disease Biomarker Testing Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 61. China Infectious Disease Biomarker Testing Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 62. Abacus Diagnostica Basic Information
Table 63. Abacus Diagnostica Infectious Disease Biomarker Testing Product Overview
Table 64. Abacus Diagnostica Infectious Disease Biomarker Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 65. Abacus Diagnostica Business Overview
Table 66. Abacus Diagnostica SWOT Analysis
Table 67. Abacus Diagnostica Recent Developments
Table 68. ALPCO Basic Information
Table 69. ALPCO Infectious Disease Biomarker Testing Product Overview
Table 70. ALPCO Infectious Disease Biomarker Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 71. ALPCO Business Overview
Table 72. ALPCO SWOT Analysis
Table 73. ALPCO Recent Developments
Table 74. Abbott Laboratories Basic Information
Table 75. Abbott Laboratories Infectious Disease Biomarker Testing Product Overview
Table 76. Abbott Laboratories Infectious Disease Biomarker Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 77. Abbott Laboratories Business Overview
Table 78. Abbott Laboratories SWOT Analysis
Table 79. Abbott Laboratories Recent Developments
Table 80. Agilent Technologies Basic Information
Table 81. Agilent Technologies Infectious Disease Biomarker Testing Product Overview
Table 82. Agilent Technologies Infectious Disease Biomarker Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 83. Agilent Technologies Business Overview
Table 84. Agilent Technologies Recent Developments
Table 85. Becton Basic Information
Table 86. Becton Infectious Disease Biomarker Testing Product Overview
Table 87. Becton Infectious Disease Biomarker Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 88. Becton Business Overview
Table 89. Becton Recent Developments
Table 90. Dickinson and Company Basic Information
Table 91. Dickinson and Company Infectious Disease Biomarker Testing Product Overview
Table 92. Dickinson and Company Infectious Disease Biomarker Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 93. Dickinson and Company Business Overview
Table 94. Dickinson and Company Recent Developments
Table 95. bioM?rieux SA Basic Information
Table 96. bioM?rieux SA Infectious Disease Biomarker Testing Product Overview
Table 97. bioM?rieux SA Infectious Disease Biomarker Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 98. bioM?rieux SA Business Overview
Table 99. bioM?rieux SA Recent Developments
Table 100. Bio-Rad Laboratories Basic Information
Table 101. Bio-Rad Laboratories Infectious Disease Biomarker Testing Product Overview
Table 102. Bio-Rad Laboratories Infectious Disease Biomarker Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 103. Bio-Rad Laboratories Business Overview
Table 104. Bio-Rad Laboratories Recent Developments
Table 105. Danaher Basic Information
Table 106. Danaher Infectious Disease Biomarker Testing Product Overview
Table 107. Danaher Infectious Disease Biomarker Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 108. Danaher Business Overview
Table 109. Danaher Recent Developments
Table 110. F. Hoffmann-La Roche Basic Information
Table 111. F. Hoffmann-La Roche Infectious Disease Biomarker Testing Product Overview
Table 112. F. Hoffmann-La Roche Infectious Disease Biomarker Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 113. F. Hoffmann-La Roche Business Overview
Table 114. F. Hoffmann-La Roche Recent Developments
Table 115. Hologic Basic Information
Table 116. Hologic Infectious Disease Biomarker Testing Product Overview
Table 117. Hologic Infectious Disease Biomarker Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 118. Hologic Business Overview
Table 119. Hologic Recent Developments
Table 120. PerkinElmer Basic Information
Table 121. PerkinElmer Infectious Disease Biomarker Testing Product Overview
Table 122. PerkinElmer Infectious Disease Biomarker Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 123. PerkinElmer Business Overview
Table 124. PerkinElmer Recent Developments
Table 125. Qiagen Basic Information
Table 126. Qiagen Infectious Disease Biomarker Testing Product Overview
Table 127. Qiagen Infectious Disease Biomarker Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 128. Qiagen Business Overview
Table 129. Qiagen Recent Developments
Table 130. Quest Diagnostics Incorporated Basic Information
Table 131. Quest Diagnostics Incorporated Infectious Disease Biomarker Testing Product Overview
Table 132. Quest Diagnostics Incorporated Infectious Disease Biomarker Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 133. Quest Diagnostics Incorporated Business Overview
Table 134. Quest Diagnostics Incorporated Recent Developments
Table 135. Siemens Healthineers Basic Information
Table 136. Siemens Healthineers Infectious Disease Biomarker Testing Product Overview
Table 137. Siemens Healthineers Infectious Disease Biomarker Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 138. Siemens Healthineers Business Overview
Table 139. Siemens Healthineers Recent Developments
Table 140. Thermo Fisher Scientific Basic Information
Table 141. Thermo Fisher Scientific Infectious Disease Biomarker Testing Product Overview
Table 142. Thermo Fisher Scientific Infectious Disease Biomarker Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 143. Thermo Fisher Scientific Business Overview
Table 144. Thermo Fisher Scientific Recent Developments
Table 145. Global Infectious Disease Biomarker Testing Sales Forecast by Region (2026-2035) & (K Units)
Table 146. Global Infectious Disease Biomarker Testing Market Size Forecast by Region (2026-2035) & (M USD)
Table 147. North America Infectious Disease Biomarker Testing Sales Forecast by Country (2026-2035) & (K Units)
Table 148. North America Infectious Disease Biomarker Testing Market Size Forecast by Country (2026-2035) & (M USD)
Table 149. Europe Infectious Disease Biomarker Testing Sales Forecast by Country (2026-2035) & (K Units)
Table 150. Europe Infectious Disease Biomarker Testing Market Size Forecast by Country (2026-2035) & (M USD)
Table 151. Asia Pacific Infectious Disease Biomarker Testing Sales Forecast by Region (2026-2035) & (K Units)
Table 152. Asia Pacific Infectious Disease Biomarker Testing Market Size Forecast by Region (2026-2035) & (M USD)
Table 153. South America Infectious Disease Biomarker Testing Sales Forecast by Country (2026-2035) & (K Units)
Table 154. South America Infectious Disease Biomarker Testing Market Size Forecast by Country (2026-2035) & (M USD)
Table 155. Middle East and Africa Infectious Disease Biomarker Testing Sales Forecast by Country (2026-2035) & (Units)
Table 156. Middle East and Africa Infectious Disease Biomarker Testing Market Size Forecast by Country (2026-2035) & (M USD)
Table 157. Global Infectious Disease Biomarker Testing Sales Forecast by Type (2026-2035) & (K Units)
Table 158. Global Infectious Disease Biomarker Testing Market Size Forecast by Type (2026-2035) & (M USD)
Table 159. Global Infectious Disease Biomarker Testing Price Forecast by Type (2026-2035) & (USD/Unit)
Table 160. Global Infectious Disease Biomarker Testing Sales (K Units) Forecast by Application (2026-2035)
Table 161. Global Infectious Disease Biomarker Testing Market Size Forecast by Application (2026-2035) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Infectious Disease Biomarker Testing Market Size by Type (M USD)
Table 4. Global Infectious Disease Biomarker Testing Market Size by Application
Table 5. Infectious Disease Biomarker Testing Market Size Comparison by Region (M USD)
Table 6. Global Infectious Disease Biomarker Testing Sales (K Units) by Manufacturers (2020-2025)
Table 7. Global Infectious Disease Biomarker Testing Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Infectious Disease Biomarker Testing Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Infectious Disease Biomarker Testing Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Infectious Disease Biomarker Testing as of 2025)
Table 11. Global Market Infectious Disease Biomarker Testing Average Price (USD/Unit) of Key Manufacturers (2020-2025)
Table 12. Manufacturers? Manufacturing Sites, Areas Served
Table 13. Manufacturers? Product Type
Table 14. Global Infectious Disease Biomarker Testing Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Infectious Disease Biomarker Testing Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2025-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2025-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2025-2026
Table 25. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 26. Global Infectious Disease Biomarker Testing Sales by Type (K Units)
Table 27. Global Infectious Disease Biomarker Testing Market Size by Type (M USD)
Table 28. Global Infectious Disease Biomarker Testing Sales (K Units) by Type (2020-2025)
Table 29. Global Infectious Disease Biomarker Testing Sales Market Share by Type (2020-2025)
Table 30. Global Infectious Disease Biomarker Testing Market Size (M USD) by Type (2020-2025)
Table 31. Global Infectious Disease Biomarker Testing Market Share by Type (2020-2025)
Table 32. Global Infectious Disease Biomarker Testing Price (USD/Unit) by Type (2020-2025)
Table 33. Global Infectious Disease Biomarker Testing Sales (K Units) by Application
Table 34. Global Infectious Disease Biomarker Testing Market Size by Application
Table 35. Global Infectious Disease Biomarker Testing Sales by Application (2020-2025) & (K Units)
Table 36. Global Infectious Disease Biomarker Testing Sales Market Share by Application (2020-2025)
Table 37. Global Infectious Disease Biomarker Testing Market Size by Application (2020-2025) & (M USD)
Table 38. Global Infectious Disease Biomarker Testing Market Share by Application (2020-2025)
Table 39. Global Infectious Disease Biomarker Testing Sales Growth Rate by Application (2020-2025)
Table 40. Global Infectious Disease Biomarker Testing Sales by Region (2020-2025) & (K Units)
Table 41. Global Infectious Disease Biomarker Testing Sales Market Share by Region (2020-2025)
Table 42. Global Infectious Disease Biomarker Testing Market Size by Region (2020-2025) & (M USD)
Table 43. Global Infectious Disease Biomarker Testing Market Size by Region (2020-2025)
Table 44. North America Infectious Disease Biomarker Testing Sales by Country (2020-2025) & (K Units)
Table 45. North America Infectious Disease Biomarker Testing Market Size by Country (2020-2025) & (M USD)
Table 46. Europe Infectious Disease Biomarker Testing Sales by Country (2020-2025) & (K Units)
Table 47. Europe Infectious Disease Biomarker Testing Market Size by Country (2020-2025) & (M USD)
Table 48. Asia Pacific Infectious Disease Biomarker Testing Sales by Region (2020-2025) & (K Units)
Table 49. Asia Pacific Infectious Disease Biomarker Testing Market Size by Region (2020-2025) & (M USD)
Table 50. South America Infectious Disease Biomarker Testing Sales by Country (2020-2025) & (K Units)
Table 51. South America Infectious Disease Biomarker Testing Market Size by Country (2020-2025) & (M USD)
Table 52. Middle East and Africa Infectious Disease Biomarker Testing Sales by Region (2020-2025) & (K Units)
Table 53. Middle East and Africa Infectious Disease Biomarker Testing Market Size by Region (2020-2025) & (M USD)
Table 54. Global Infectious Disease Biomarker Testing Production (K Units) by Region(2020-2025)
Table 55. Global Infectious Disease Biomarker Testing Revenue (US$ Million) by Region (2020-2025)
Table 56. Global Infectious Disease Biomarker Testing Revenue Market Share by Region (2020-2025)
Table 57. Global Infectious Disease Biomarker Testing Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 58. North America Infectious Disease Biomarker Testing Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 59. Europe Infectious Disease Biomarker Testing Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 60. Japan Infectious Disease Biomarker Testing Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 61. China Infectious Disease Biomarker Testing Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 62. Abacus Diagnostica Basic Information
Table 63. Abacus Diagnostica Infectious Disease Biomarker Testing Product Overview
Table 64. Abacus Diagnostica Infectious Disease Biomarker Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 65. Abacus Diagnostica Business Overview
Table 66. Abacus Diagnostica SWOT Analysis
Table 67. Abacus Diagnostica Recent Developments
Table 68. ALPCO Basic Information
Table 69. ALPCO Infectious Disease Biomarker Testing Product Overview
Table 70. ALPCO Infectious Disease Biomarker Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 71. ALPCO Business Overview
Table 72. ALPCO SWOT Analysis
Table 73. ALPCO Recent Developments
Table 74. Abbott Laboratories Basic Information
Table 75. Abbott Laboratories Infectious Disease Biomarker Testing Product Overview
Table 76. Abbott Laboratories Infectious Disease Biomarker Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 77. Abbott Laboratories Business Overview
Table 78. Abbott Laboratories SWOT Analysis
Table 79. Abbott Laboratories Recent Developments
Table 80. Agilent Technologies Basic Information
Table 81. Agilent Technologies Infectious Disease Biomarker Testing Product Overview
Table 82. Agilent Technologies Infectious Disease Biomarker Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 83. Agilent Technologies Business Overview
Table 84. Agilent Technologies Recent Developments
Table 85. Becton Basic Information
Table 86. Becton Infectious Disease Biomarker Testing Product Overview
Table 87. Becton Infectious Disease Biomarker Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 88. Becton Business Overview
Table 89. Becton Recent Developments
Table 90. Dickinson and Company Basic Information
Table 91. Dickinson and Company Infectious Disease Biomarker Testing Product Overview
Table 92. Dickinson and Company Infectious Disease Biomarker Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 93. Dickinson and Company Business Overview
Table 94. Dickinson and Company Recent Developments
Table 95. bioM?rieux SA Basic Information
Table 96. bioM?rieux SA Infectious Disease Biomarker Testing Product Overview
Table 97. bioM?rieux SA Infectious Disease Biomarker Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 98. bioM?rieux SA Business Overview
Table 99. bioM?rieux SA Recent Developments
Table 100. Bio-Rad Laboratories Basic Information
Table 101. Bio-Rad Laboratories Infectious Disease Biomarker Testing Product Overview
Table 102. Bio-Rad Laboratories Infectious Disease Biomarker Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 103. Bio-Rad Laboratories Business Overview
Table 104. Bio-Rad Laboratories Recent Developments
Table 105. Danaher Basic Information
Table 106. Danaher Infectious Disease Biomarker Testing Product Overview
Table 107. Danaher Infectious Disease Biomarker Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 108. Danaher Business Overview
Table 109. Danaher Recent Developments
Table 110. F. Hoffmann-La Roche Basic Information
Table 111. F. Hoffmann-La Roche Infectious Disease Biomarker Testing Product Overview
Table 112. F. Hoffmann-La Roche Infectious Disease Biomarker Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 113. F. Hoffmann-La Roche Business Overview
Table 114. F. Hoffmann-La Roche Recent Developments
Table 115. Hologic Basic Information
Table 116. Hologic Infectious Disease Biomarker Testing Product Overview
Table 117. Hologic Infectious Disease Biomarker Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 118. Hologic Business Overview
Table 119. Hologic Recent Developments
Table 120. PerkinElmer Basic Information
Table 121. PerkinElmer Infectious Disease Biomarker Testing Product Overview
Table 122. PerkinElmer Infectious Disease Biomarker Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 123. PerkinElmer Business Overview
Table 124. PerkinElmer Recent Developments
Table 125. Qiagen Basic Information
Table 126. Qiagen Infectious Disease Biomarker Testing Product Overview
Table 127. Qiagen Infectious Disease Biomarker Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 128. Qiagen Business Overview
Table 129. Qiagen Recent Developments
Table 130. Quest Diagnostics Incorporated Basic Information
Table 131. Quest Diagnostics Incorporated Infectious Disease Biomarker Testing Product Overview
Table 132. Quest Diagnostics Incorporated Infectious Disease Biomarker Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 133. Quest Diagnostics Incorporated Business Overview
Table 134. Quest Diagnostics Incorporated Recent Developments
Table 135. Siemens Healthineers Basic Information
Table 136. Siemens Healthineers Infectious Disease Biomarker Testing Product Overview
Table 137. Siemens Healthineers Infectious Disease Biomarker Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 138. Siemens Healthineers Business Overview
Table 139. Siemens Healthineers Recent Developments
Table 140. Thermo Fisher Scientific Basic Information
Table 141. Thermo Fisher Scientific Infectious Disease Biomarker Testing Product Overview
Table 142. Thermo Fisher Scientific Infectious Disease Biomarker Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 143. Thermo Fisher Scientific Business Overview
Table 144. Thermo Fisher Scientific Recent Developments
Table 145. Global Infectious Disease Biomarker Testing Sales Forecast by Region (2026-2035) & (K Units)
Table 146. Global Infectious Disease Biomarker Testing Market Size Forecast by Region (2026-2035) & (M USD)
Table 147. North America Infectious Disease Biomarker Testing Sales Forecast by Country (2026-2035) & (K Units)
Table 148. North America Infectious Disease Biomarker Testing Market Size Forecast by Country (2026-2035) & (M USD)
Table 149. Europe Infectious Disease Biomarker Testing Sales Forecast by Country (2026-2035) & (K Units)
Table 150. Europe Infectious Disease Biomarker Testing Market Size Forecast by Country (2026-2035) & (M USD)
Table 151. Asia Pacific Infectious Disease Biomarker Testing Sales Forecast by Region (2026-2035) & (K Units)
Table 152. Asia Pacific Infectious Disease Biomarker Testing Market Size Forecast by Region (2026-2035) & (M USD)
Table 153. South America Infectious Disease Biomarker Testing Sales Forecast by Country (2026-2035) & (K Units)
Table 154. South America Infectious Disease Biomarker Testing Market Size Forecast by Country (2026-2035) & (M USD)
Table 155. Middle East and Africa Infectious Disease Biomarker Testing Sales Forecast by Country (2026-2035) & (Units)
Table 156. Middle East and Africa Infectious Disease Biomarker Testing Market Size Forecast by Country (2026-2035) & (M USD)
Table 157. Global Infectious Disease Biomarker Testing Sales Forecast by Type (2026-2035) & (K Units)
Table 158. Global Infectious Disease Biomarker Testing Market Size Forecast by Type (2026-2035) & (M USD)
Table 159. Global Infectious Disease Biomarker Testing Price Forecast by Type (2026-2035) & (USD/Unit)
Table 160. Global Infectious Disease Biomarker Testing Sales (K Units) Forecast by Application (2026-2035)
Table 161. Global Infectious Disease Biomarker Testing Market Size Forecast by Application (2026-2035) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Infectious Disease Biomarker Testing
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Infectious Disease Biomarker Testing Market Size (M USD), 2025-2035
Figure 5. Global Infectious Disease Biomarker Testing Market Size (M USD) (2020-2035)
Figure 6. Global Infectious Disease Biomarker Testing Sales (K Units) & (2020-2035)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Infectious Disease Biomarker Testing Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Infectious Disease Biomarker Testing Product Life Cycle
Figure 13. Infectious Disease Biomarker Testing Sales Share by Manufacturers in 2025
Figure 14. Global Infectious Disease Biomarker Testing Revenue Share by Manufacturers in 2025
Figure 15. Infectious Disease Biomarker Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 16. Global Market Infectious Disease Biomarker Testing Average Price (USD/Unit) of Key Manufacturers in 2025
Figure 17. The Global 5 and 10 Largest Players: Market Share by Infectious Disease Biomarker Testing Revenue in 2025
Figure 18. Industry Chain Map of Infectious Disease Biomarker Testing
Figure 19. Global Infectious Disease Biomarker Testing Market PEST Analysis
Figure 20. Global Infectious Disease Biomarker Testing Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Infectious Disease Biomarker Testing Market Share by Type
Figure 27. Sales Market Share of Infectious Disease Biomarker Testing by Type (2020-2025)
Figure 28. Sales Market Share of Infectious Disease Biomarker Testing by Type in 2025
Figure 29. Market Share of Infectious Disease Biomarker Testing by Type (2020-2025)
Figure 30. Market Share of Infectious Disease Biomarker Testing by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Infectious Disease Biomarker Testing Market Share by Application
Figure 33. Global Infectious Disease Biomarker Testing Sales Market Share by Application (2020-2025)
Figure 34. Global Infectious Disease Biomarker Testing Sales Market Share by Application in 2025
Figure 35. Global Infectious Disease Biomarker Testing Market Share by Application (2020-2025)
Figure 36. Global Infectious Disease Biomarker Testing Market Share by Application in 2025
Figure 37. Global Infectious Disease Biomarker Testing Sales Growth Rate by Application (2020-2025)
Figure 38. Global Infectious Disease Biomarker Testing Sales Market Share by Region (2020-2025)
Figure 39. Global Infectious Disease Biomarker Testing Market Size by Region (2020-2025)
Figure 40. North America Infectious Disease Biomarker Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 41. North America Infectious Disease Biomarker Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 42. North America Infectious Disease Biomarker Testing Sales Market Share by Country in 2024
Figure 43. North America Infectious Disease Biomarker Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Infectious Disease Biomarker Testing Market Size by Country in 2024
Figure 45. U.S. Infectious Disease Biomarker Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 46. U.S. Infectious Disease Biomarker Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Infectious Disease Biomarker Testing Sales (K Units) and Growth Rate (2020-2025)
Figure 48. Canada Infectious Disease Biomarker Testing Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Infectious Disease Biomarker Testing Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Infectious Disease Biomarker Testing Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Infectious Disease Biomarker Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 52. Europe Infectious Disease Biomarker Testing Sales Market Share by Country in 2024
Figure 53. Europe Infectious Disease Biomarker Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Infectious Disease Biomarker Testing Market Size by Country in 2024
Figure 55. Germany Infectious Disease Biomarker Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 56. Germany Infectious Disease Biomarker Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Infectious Disease Biomarker Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 58. France Infectious Disease Biomarker Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Infectious Disease Biomarker Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 60. U.K. Infectious Disease Biomarker Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Infectious Disease Biomarker Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 62. Italy Infectious Disease Biomarker Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Infectious Disease Biomarker Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 64. Spain Infectious Disease Biomarker Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Infectious Disease Biomarker Testing Sales and Growth Rate (K Units)
Figure 66. Asia Pacific Infectious Disease Biomarker Testing Sales Market Share by Region in 2024
Figure 67. Asia Pacific Infectious Disease Biomarker Testing Market Size by Region in 2024
Figure 68. China Infectious Disease Biomarker Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 69. China Infectious Disease Biomarker Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Infectious Disease Biomarker Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 71. Japan Infectious Disease Biomarker Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Infectious Disease Biomarker Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 73. South Korea Infectious Disease Biomarker Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Infectious Disease Biomarker Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 75. India Infectious Disease Biomarker Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Infectious Disease Biomarker Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 77. Southeast Asia Infectious Disease Biomarker Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Infectious Disease Biomarker Testing Sales and Growth Rate (K Units)
Figure 79. South America Infectious Disease Biomarker Testing Sales Market Share by Country in 2024
Figure 80. South America Infectious Disease Biomarker Testing Market Size and Growth Rate (M USD)
Figure 81. South America Infectious Disease Biomarker Testing Market Size by Country in 2024
Figure 82. Brazil Infectious Disease Biomarker Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 83. Brazil Infectious Disease Biomarker Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Infectious Disease Biomarker Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 85. Argentina Infectious Disease Biomarker Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Infectious Disease Biomarker Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 87. Columbia Infectious Disease Biomarker Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Infectious Disease Biomarker Testing Sales and Growth Rate (K Units)
Figure 89. Middle East and Africa Infectious Disease Biomarker Testing Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Infectious Disease Biomarker Testing Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Infectious Disease Biomarker Testing Market Size by Region in 2024
Figure 92. Saudi Arabia Infectious Disease Biomarker Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 93. Saudi Arabia Infectious Disease Biomarker Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Infectious Disease Biomarker Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 95. UAE Infectious Disease Biomarker Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Infectious Disease Biomarker Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 97. Egypt Infectious Disease Biomarker Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Infectious Disease Biomarker Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 99. Nigeria Infectious Disease Biomarker Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Infectious Disease Biomarker Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 101. South Africa Infectious Disease Biomarker Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Infectious Disease Biomarker Testing Production Market Share by Region (2020-2025)
Figure 103. North America Infectious Disease Biomarker Testing Production (K Units) Growth Rate (2020-2025)
Figure 104. Europe Infectious Disease Biomarker Testing Production (K Units) Growth Rate (2020-2025)
Figure 105. Japan Infectious Disease Biomarker Testing Production (K Units) Growth Rate (2020-2025)
Figure 106. China Infectious Disease Biomarker Testing Production (K Units) Growth Rate (2020-2025)
Figure 107. Global Infectious Disease Biomarker Testing Sales Forecast by Volume (2020-2035) & (K Units)
Figure 108. Global Infectious Disease Biomarker Testing Market Size Forecast by Value (2020-2035) & (M USD)
Figure 109. Global Infectious Disease Biomarker Testing Sales Market Share Forecast by Type (2026-2035)
Figure 110. Global Infectious Disease Biomarker Testing Market Share Forecast by Type (2026-2035)
Figure 111. Global Infectious Disease Biomarker Testing Sales Forecast by Application (2026-2035)
Figure 112. Global Infectious Disease Biomarker Testing Market Share Forecast by Application (2026-2035)
Figure 1. Product Picture of Infectious Disease Biomarker Testing
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Infectious Disease Biomarker Testing Market Size (M USD), 2025-2035
Figure 5. Global Infectious Disease Biomarker Testing Market Size (M USD) (2020-2035)
Figure 6. Global Infectious Disease Biomarker Testing Sales (K Units) & (2020-2035)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Infectious Disease Biomarker Testing Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Infectious Disease Biomarker Testing Product Life Cycle
Figure 13. Infectious Disease Biomarker Testing Sales Share by Manufacturers in 2025
Figure 14. Global Infectious Disease Biomarker Testing Revenue Share by Manufacturers in 2025
Figure 15. Infectious Disease Biomarker Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 16. Global Market Infectious Disease Biomarker Testing Average Price (USD/Unit) of Key Manufacturers in 2025
Figure 17. The Global 5 and 10 Largest Players: Market Share by Infectious Disease Biomarker Testing Revenue in 2025
Figure 18. Industry Chain Map of Infectious Disease Biomarker Testing
Figure 19. Global Infectious Disease Biomarker Testing Market PEST Analysis
Figure 20. Global Infectious Disease Biomarker Testing Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Infectious Disease Biomarker Testing Market Share by Type
Figure 27. Sales Market Share of Infectious Disease Biomarker Testing by Type (2020-2025)
Figure 28. Sales Market Share of Infectious Disease Biomarker Testing by Type in 2025
Figure 29. Market Share of Infectious Disease Biomarker Testing by Type (2020-2025)
Figure 30. Market Share of Infectious Disease Biomarker Testing by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Infectious Disease Biomarker Testing Market Share by Application
Figure 33. Global Infectious Disease Biomarker Testing Sales Market Share by Application (2020-2025)
Figure 34. Global Infectious Disease Biomarker Testing Sales Market Share by Application in 2025
Figure 35. Global Infectious Disease Biomarker Testing Market Share by Application (2020-2025)
Figure 36. Global Infectious Disease Biomarker Testing Market Share by Application in 2025
Figure 37. Global Infectious Disease Biomarker Testing Sales Growth Rate by Application (2020-2025)
Figure 38. Global Infectious Disease Biomarker Testing Sales Market Share by Region (2020-2025)
Figure 39. Global Infectious Disease Biomarker Testing Market Size by Region (2020-2025)
Figure 40. North America Infectious Disease Biomarker Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 41. North America Infectious Disease Biomarker Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 42. North America Infectious Disease Biomarker Testing Sales Market Share by Country in 2024
Figure 43. North America Infectious Disease Biomarker Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Infectious Disease Biomarker Testing Market Size by Country in 2024
Figure 45. U.S. Infectious Disease Biomarker Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 46. U.S. Infectious Disease Biomarker Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Infectious Disease Biomarker Testing Sales (K Units) and Growth Rate (2020-2025)
Figure 48. Canada Infectious Disease Biomarker Testing Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Infectious Disease Biomarker Testing Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Infectious Disease Biomarker Testing Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Infectious Disease Biomarker Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 52. Europe Infectious Disease Biomarker Testing Sales Market Share by Country in 2024
Figure 53. Europe Infectious Disease Biomarker Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Infectious Disease Biomarker Testing Market Size by Country in 2024
Figure 55. Germany Infectious Disease Biomarker Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 56. Germany Infectious Disease Biomarker Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Infectious Disease Biomarker Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 58. France Infectious Disease Biomarker Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Infectious Disease Biomarker Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 60. U.K. Infectious Disease Biomarker Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Infectious Disease Biomarker Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 62. Italy Infectious Disease Biomarker Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Infectious Disease Biomarker Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 64. Spain Infectious Disease Biomarker Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Infectious Disease Biomarker Testing Sales and Growth Rate (K Units)
Figure 66. Asia Pacific Infectious Disease Biomarker Testing Sales Market Share by Region in 2024
Figure 67. Asia Pacific Infectious Disease Biomarker Testing Market Size by Region in 2024
Figure 68. China Infectious Disease Biomarker Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 69. China Infectious Disease Biomarker Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Infectious Disease Biomarker Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 71. Japan Infectious Disease Biomarker Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Infectious Disease Biomarker Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 73. South Korea Infectious Disease Biomarker Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Infectious Disease Biomarker Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 75. India Infectious Disease Biomarker Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Infectious Disease Biomarker Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 77. Southeast Asia Infectious Disease Biomarker Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Infectious Disease Biomarker Testing Sales and Growth Rate (K Units)
Figure 79. South America Infectious Disease Biomarker Testing Sales Market Share by Country in 2024
Figure 80. South America Infectious Disease Biomarker Testing Market Size and Growth Rate (M USD)
Figure 81. South America Infectious Disease Biomarker Testing Market Size by Country in 2024
Figure 82. Brazil Infectious Disease Biomarker Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 83. Brazil Infectious Disease Biomarker Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Infectious Disease Biomarker Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 85. Argentina Infectious Disease Biomarker Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Infectious Disease Biomarker Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 87. Columbia Infectious Disease Biomarker Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Infectious Disease Biomarker Testing Sales and Growth Rate (K Units)
Figure 89. Middle East and Africa Infectious Disease Biomarker Testing Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Infectious Disease Biomarker Testing Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Infectious Disease Biomarker Testing Market Size by Region in 2024
Figure 92. Saudi Arabia Infectious Disease Biomarker Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 93. Saudi Arabia Infectious Disease Biomarker Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Infectious Disease Biomarker Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 95. UAE Infectious Disease Biomarker Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Infectious Disease Biomarker Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 97. Egypt Infectious Disease Biomarker Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Infectious Disease Biomarker Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 99. Nigeria Infectious Disease Biomarker Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Infectious Disease Biomarker Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 101. South Africa Infectious Disease Biomarker Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Infectious Disease Biomarker Testing Production Market Share by Region (2020-2025)
Figure 103. North America Infectious Disease Biomarker Testing Production (K Units) Growth Rate (2020-2025)
Figure 104. Europe Infectious Disease Biomarker Testing Production (K Units) Growth Rate (2020-2025)
Figure 105. Japan Infectious Disease Biomarker Testing Production (K Units) Growth Rate (2020-2025)
Figure 106. China Infectious Disease Biomarker Testing Production (K Units) Growth Rate (2020-2025)
Figure 107. Global Infectious Disease Biomarker Testing Sales Forecast by Volume (2020-2035) & (K Units)
Figure 108. Global Infectious Disease Biomarker Testing Market Size Forecast by Value (2020-2035) & (M USD)
Figure 109. Global Infectious Disease Biomarker Testing Sales Market Share Forecast by Type (2026-2035)
Figure 110. Global Infectious Disease Biomarker Testing Market Share Forecast by Type (2026-2035)
Figure 111. Global Infectious Disease Biomarker Testing Sales Forecast by Application (2026-2035)
Figure 112. Global Infectious Disease Biomarker Testing Market Share Forecast by Application (2026-2035)
